t(15;17)
specificA cytogenetic abnormality that involves a translocation between chromosomes 15 and 17.
12
Centers
12
Active Trials
—
Cancer Funding
Top Centers for t(15;17)(12)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 54.2 |
| 2 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 54.2 |
| 3 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 54.2 |
| 4 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 54.2 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.2 |
| 6 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 54.2 |
| 7 | University of Illinois Cancer CenterChicago, IL Active Research Program | 54.2 |
| 8 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 54.2 |
| 9 | Cancer Center at IllinoisUrbana, IL Active Research Program | 54.2 |
| 10 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 54.2 |
| 11 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 54.2 |
| 12 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 54.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →